I do. However I'm not so sure sales will ramp that quickly. Lots of variables. Mainly insurance coverage. If V is T2 across the board in the next few months no worries. Just don't want to see anymore dilution.
Even if RI is a success, the company still has to file sNDA for label extension, and FDA may take 2-6 months to review. JMO. And I understand that with a success RI readout, the market will react right away and keeps reacting for a period of times (a few years ?) due to the Rx running up.
News 
Market Data 
Discover 
